Thu, March 15, 2012
[ Thu, Mar 15th 2012 ] - Market Wire
Boston Scientific Announces Health Canada Approval of Blazera" Open-Irrigated Catheter
[ Thu, Mar 15th 2012 ] - Market Wire
Cytomedix Announces Publication in American Heart .. e Phase I Clinical Data Using ALD-201 to Treat Is
[ Thu, Mar 15th 2012 ] - Market Wire
LifeVantage Corp. Featured in March's OTC Growth Stock Watch Newsletter
[ Thu, Mar 15th 2012 ] - Market Wire
Cynosure Introduces Enhanced Elite+ and Apogee+ Workstations for Faster Aesthetic Treatments
[ Thu, Mar 15th 2012 ] - Market Wire
Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors
[ Thu, Mar 15th 2012 ] - Market Wire
Celsion Reports Year End 2011 Financial Results and Provides Business Update
[ Thu, Mar 15th 2012 ] - Market Wire
Unigene Appoints David Moskowitz as Chief Financial Officer
[ Thu, Mar 15th 2012 ] - Market Wire
GenVec Reports Fourth Quarter and 2011 Year-End Financial Results
[ Thu, Mar 15th 2012 ] - Market Wire
Given Imaging to Present at the Maxim Group Growth Conference on March 26, 2012
[ Thu, Mar 15th 2012 ] - Market Wire
Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
[ Thu, Mar 15th 2012 ] - Market Wire
United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents
[ Thu, Mar 15th 2012 ] - Market Wire
Amedisys Scores 19% Above National Average on Treatment Goals Met at Home
[ Thu, Mar 15th 2012 ] - Market Wire
DaVita Clinics Give $67,000 to Ohio Charities
[ Thu, Mar 15th 2012 ] - Market Wire
Delcath Announces Agreement With Institut Gustave .. nch of Hepatic CHEMOSAT Delivery System in France
[ Thu, Mar 15th 2012 ] - Market Wire
InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update
[ Thu, Mar 15th 2012 ] - Market Wire
Abbott Announces Patient Enrollment in Two Phase .. ab) for Moderate to Severe Hidradenitis Suppurati
[ Thu, Mar 15th 2012 ] - Market Wire
PAREXEL Global Survey Results Identify Top Concer .. iopharma Industry in Achieving Commercial Success
Wed, March 14, 2012
[ Wed, Mar 14th 2012 ] - Market Wire
Flamel Technologies Announces Acquisition of clat Pharmaceuticals
[ Wed, Mar 14th 2012 ] - Market Wire
Teva Announces Launch of Generic Lexapro in the U .. ; Awarded 180-Day Period of Marketing Exclusivity
[ Wed, Mar 14th 2012 ] - Market Wire
Guided Therapeutics to Report Q4 2011 Results and Hold Conference Call
[ Wed, Mar 14th 2012 ] - Market Wire
Securities Lawyers Seeking More Money, Informatio .. es Stockholders in Buyout, Announces Goldfarb LLP
[ Wed, Mar 14th 2012 ] - Market Wire
Goldfarb LLP Securities Lawyers Seek More Money, .. formation for Shareholders in Zoll Medical Buyout
[ Wed, Mar 14th 2012 ] - Market Wire
Biogen Idec Takes Option to MAKScientific MS Program
[ Wed, Mar 14th 2012 ] - Market Wire
Generex Subsidiary Antigen Express Announces Publ .. its Proprietary Therapeutic Vaccine Technology in
[ Wed, Mar 14th 2012 ] - Market Wire
Covidien dichiara dividendo liquido trimestrale
[ Wed, Mar 14th 2012 ] - Market Wire
Threshold Pharmaceuticals Doses First Patient in .. nical Trial Evaluating TH-302 in Multiple Myeloma
[ Wed, Mar 14th 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation Provides Update on Operational Leadership
[ Wed, Mar 14th 2012 ] - Market Wire
Verastem, Inc. Reports Year-End 2011 Financial Results
[ Wed, Mar 14th 2012 ] - Market Wire
Covidien meldt resultaten van 2012 jaarlijkse algemene vergadering
[ Wed, Mar 14th 2012 ] - Market Wire
DaVita Thanks its 1,500 Dietitianson Registered Dietitian Day
[ Wed, Mar 14th 2012 ] - Market Wire
Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation
[ Wed, Mar 14th 2012 ] - Market Wire
Alnylam Retains Key Claims for Kinesin Spindle Pr .. ein (KSP) RNAi Patent in Interference Proceedings
[ Wed, Mar 14th 2012 ] - Market Wire
Synthetic Biologics Announces Completion of Enrol .. l Trial of Oral Trimestaa" for Multiple Sclerosis
[ Wed, Mar 14th 2012 ] - Market Wire
Marina Biotech and ProNAi Therapeutics Announce L .. nt for the Development of DNAi-Based Therapeutics
[ Wed, Mar 14th 2012 ] - Market Wire
OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial
[ Wed, Mar 14th 2012 ] - Market Wire
Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data
[ Wed, Mar 14th 2012 ] - Market Wire
Perceptive Informatics Global Survey Results Show .. ption of Web-based RTSM Systems by Clinical Sites
Tue, March 13, 2012
[ Tue, Mar 13th 2012 ] - Market Wire
Medivation, Inc. Prices $225 Million 2.625% Convertible Senior Notes Due 2017
[ Tue, Mar 13th 2012 ] - Market Wire
Kensey Nash Corporation Declares a Quarterly Dividend of $0.25 Per Share
[ Tue, Mar 13th 2012 ] - Market Wire
ActiveCare Acquires 4G Biometrics in Move to Addr .. ing Needs of Diabetic Patients and Their Families
[ Tue, Mar 13th 2012 ] - Market Wire
SciClone Reports Financial Results for the Fourth Quarter and Year 2011 and Outlook for 2012
[ Tue, Mar 13th 2012 ] - Market Wire
VELscope Vx(R) Approved for Use by AppleWhite Dental Partners
[ Tue, Mar 13th 2012 ] - Market Wire
Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan
[ Tue, Mar 13th 2012 ] - Market Wire
Endo Files Amended Citizen Petition Seeking Publi .. Safety and Efficacy Issues Prior to Approval of a
[ Tue, Mar 13th 2012 ] - Market Wire
NuPathe to Report Fourth Quarter and Full Year 20 .. d Hold Conference Call on Tuesday, March 20, 2012
[ Tue, Mar 13th 2012 ] - Market Wire
Comprehensive Care Corporation Celebrates 43rd Anniversary
[ Tue, Mar 13th 2012 ] - Market Wire
Enzo Biochemas Clinical Laboratory Applies for NY .. oval for First Assay Based on Its AmpiProbea" Amp
[ Tue, Mar 13th 2012 ] - Market Wire
Codexis to Present at Sidotias Emerging Growth Institutional Investor Forum
[ Tue, Mar 13th 2012 ] - Market Wire
Columbia Laboratories Hires Cowen and Company to .. st in Evaluating Potential Strategic Transactions
[ Tue, Mar 13th 2012 ] - Market Wire
OncoSec President and CEO Contributes to Today's Medical Developments
[ Tue, Mar 13th 2012 ] - Market Wire
Aeolus to Present at Roth Capital Partners' 24th Annual Growth Stock Conference
[ Tue, Mar 13th 2012 ] - Market Wire
Boston Scientific vor der bernahme von Cameron Health, Inc.
[ Tue, Mar 13th 2012 ] - Market Wire
Boston Scientific comprar Cameron Health, Inc.
[ Tue, Mar 13th 2012 ] - Market Wire
Acquisition de Cameron Health, Inc. par Boston Scientific
[ Tue, Mar 13th 2012 ] - Market Wire
Boston Scientific annuncia l'acquisizione di Cameron Health, Inc.
[ Tue, Mar 13th 2012 ] - Market Wire
Inovio Pharmaceuticals' PENNVAX-B HIV Vaccine Dem .. ell Immune Responses in Therapeutic Vaccine Trial
[ Tue, Mar 13th 2012 ] - Market Wire
AstraZeneca Files Lawsuit against the FDA for Dec .. rding Quetiapine Product Labeling and Exclusivity
Mon, March 12, 2012
[ Mon, Mar 12th 2012 ] - Market Wire
Cannabis Science Confirms Target Indication for F .. eeting with the FDA with Its Team of FDA Speciali
[ Mon, Mar 12th 2012 ] - Market Wire
Syneron to Acquire Assets of TransPharma Medical Ltd.
[ Mon, Mar 12th 2012 ] - Market Wire
Lpath Prepares to Continue iSONEP Trials in August
[ Mon, Mar 12th 2012 ] - Market Wire
Pfizer and Bristol-Myers Squibb Look to Reshape Anticoagulant Market
[ Mon, Mar 12th 2012 ] - Market Wire
Equity Research on Mylan Inc. and Watson Pharmace .. Makers Continue to Capitalize on Expiring Patents
[ Mon, Mar 12th 2012 ] - Market Wire
American Medical Association Adopts New Category III CPT Codes for Vagus Nerve Blocking Therapy
[ Mon, Mar 12th 2012 ] - Market Wire
Enzon Reports Fourth-Quarter and Full-Year 2011 Results
[ Mon, Mar 12th 2012 ] - Market Wire
Valeant Pharmaceuticals Acquires a 19.9% Minority Equity Investment in Biotech Company in Brazil
[ Mon, Mar 12th 2012 ] - Market Wire
WaferGen Appoints Ivan Trifunovich President, CEO, and Director
[ Mon, Mar 12th 2012 ] - Market Wire
Infinity Appoints Two Experienced Industry Leaders to Its Board of Directors
[ Mon, Mar 12th 2012 ] - Market Wire
Zynex Acquires NeuroDyne Medical, Corp.
[ Mon, Mar 12th 2012 ] - Market Wire
International Stem Cell Corporation Completes $5 .. and Elects Jim Berglund to the Board of Directors
[ Mon, Mar 12th 2012 ] - Market Wire
ImmunoCellular Therapeutics Reports Manufacturing Process Data for ICT-107
[ Mon, Mar 12th 2012 ] - Market Wire
Threshold Pharmaceuticals' TH-302 to Be Featured .. Cancer Hosted by the New York Academy of Sciences
[ Mon, Mar 12th 2012 ] - Market Wire
ONSOLIS Relaunch Postponed Pending Product Modification
[ Mon, Mar 12th 2012 ] - Market Wire
Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy
[ Mon, Mar 12th 2012 ] - Market Wire
Teleflex Appoints Thomas E. Powell Senior Vice President & Chief Financial Officer
[ Mon, Mar 12th 2012 ] - Market Wire
PAREXEL Experts to Address Approaches to Accelera .. ase Development Decisions at ASCPT Annual Meeting
[ Mon, Mar 12th 2012 ] - Market Wire
Medisafe 1 Technologies Signs Marketing and Distribution Agreement with Health Product Carrier
[ Mon, Mar 12th 2012 ] - Market Wire
Sunshine Heart Provides FAQ Regarding Transmutation of CDIs to Common Stock
Sat, March 10, 2012
[ Sat, Mar 10th 2012 ] - Market Wire
Gegevens tonen aan dat Gilead';;s .. ferieur is aan op protease gebaseerd regime na 48
[ Sat, Mar 10th 2012 ] - Market Wire
I dati di un secondo importante studio di Fase II .. t del regime Quad di Gilead per il trattamento de
[ Sat, Mar 10th 2012 ] - Market Wire
Quad-HIV-Prparat von Gilead nach 48 Wochen nicht .. g auf Protease-Basis: Beleg durch Daten einer zwe
[ Sat, Mar 10th 2012 ] - Market Wire
Los datos muestran que el rgimen Quad de Gilead p .. rgimen basado en proteasa a las 48 semanas en un
[ Sat, Mar 10th 2012 ] - Market Wire
Gegevens tonen aan dat Gilead's Quad-regime voor .. protease gebaseerd regime na 48 weken, in tweede
[ Sat, Mar 10th 2012 ] - Market Wire
Tenet to Speak at the Barclays Capital Healthcare Conference on March 14th
[ Sat, Mar 10th 2012 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Lead Plain .. e In The Class Action Lawsuit Against TranS1 Inc.
Fri, March 9, 2012
[ Fri, Mar 09th 2012 ] - Market Wire
Edwards Lifesciences to Present at the 24th Annual ROTH Conference
[ Fri, Mar 09th 2012 ] - Market Wire
Cynapsus Therapeutics Announces $1 Million Financing
[ Fri, Mar 09th 2012 ] - Market Wire
Patient Home Monitoring (PHM) Announces February .. s and Growth Figures, Change in Operation Executi
[ Fri, Mar 09th 2012 ] - Market Wire
The Law Firm of Levi amp;; Korsinsky, LLP .. anscend Services, Inc. in Connection with the Sal
[ Fri, Mar 09th 2012 ] - Market Wire
Titan Medical Inc. Files Prospectus Supplement for Unit Offering
[ Fri, Mar 09th 2012 ] - Market Wire
Regeneron Announces Change in Date for Presentati .. arclays Capital 2012 Global Healthcare Conference
[ Fri, Mar 09th 2012 ] - Market Wire
Is Health Discovery Corporation Finally on the Verge of a Turnaround?
[ Fri, Mar 09th 2012 ] - Market Wire
Sequenom, Genworth Financial, Huntsman, New Gold, Huntington Bancshares, and Amarin
[ Fri, Mar 09th 2012 ] - Market Wire
Cantel Medical Corp. to Present at the Sidoti amp .. nth Annual Emerging Growth Institutional Investor
[ Fri, Mar 09th 2012 ] - Market Wire
(NYSE Amex: DXR) Daxor Announces Filing of Two Ad .. onal Patents for Updated Automated Blood Analyzer
[ Fri, Mar 09th 2012 ] - Market Wire
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on PhotoMedex, Inc.
[ Fri, Mar 09th 2012 ] - Market Wire
Ardea Biosciences Reports Recent Accomplishments .. urth Quarter and Full-Year 2011 Financial Results
[ Fri, Mar 09th 2012 ] - Market Wire
BD to Present at the Barclays Capital Global Healthcare Conference
[ Fri, Mar 09th 2012 ] - Market Wire
Equity Research on Valeant Pharmaceuticals Intern .. n Corp. plc - Drug Delivery Companies Up and Down
[ Fri, Mar 09th 2012 ] - Market Wire
Peregrine Reports Data From Phase II Front-Line Lung Cancer Trial
[ Fri, Mar 09th 2012 ] - Market Wire
Haemonetics Sets Date for Investor/Analyst Meeting
[ Fri, Mar 09th 2012 ] - Market Wire
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2011 Financial Results
[ Fri, Mar 09th 2012 ] - Market Wire
EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results
[ Fri, Mar 09th 2012 ] - Market Wire
Halozyme Reports Fourth Quarter and Year End 2011 Financial Results and Provides Guidance for 2012
[ Fri, Mar 09th 2012 ] - Market Wire
Delcath Selects Quintiles to Support EU Launch of CHEMOSAT
Thu, March 8, 2012
[ Thu, Mar 08th 2012 ] - Market Wire
Boston Scientific to Acquire Cameron Health, Inc.
[ Thu, Mar 08th 2012 ] - Market Wire
BIOLASE Chief Executive Officer to Continue at Rate of $1.00 Annual Salary
[ Thu, Mar 08th 2012 ] - Market Wire
PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
[ Thu, Mar 08th 2012 ] - Market Wire
OncoGenex Pharmaceuticals, Inc. Reports Financial .. and Year End 2011 and Provides Update on Clinical
[ Thu, Mar 08th 2012 ] - Market Wire
Sangamo Presents New Clinical Data at CROI 2012 D .. ive Effects of ZFN Therapeutic for "Functional Cu
[ Thu, Mar 08th 2012 ] - Market Wire
Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance
[ Thu, Mar 08th 2012 ] - Market Wire
LED Dental Launches Second Step Laboratory Services in Canada
[ Thu, Mar 08th 2012 ] - Market Wire
Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock
[ Thu, Mar 08th 2012 ] - Market Wire
USANA Health Sciences Unveils New Charitable Foundation
[ Thu, Mar 08th 2012 ] - Market Wire
MIT Agrees to $3.2 Million in Financing, Includin .. in Convertible Debentures and $1.2 Million in Deb
[ Thu, Mar 08th 2012 ] - Market Wire
Celsion Corporation to Hold Year-End 2011 Financi .. sults Conference Call on Thursday, March 15, 2012
[ Thu, Mar 08th 2012 ] - Market Wire
Palatin Technologies Completes Enrollment in Phas .. 2B Bremelanotide Female Sexual Dysfunction Trial
[ Thu, Mar 08th 2012 ] - Market Wire
Michael E. DeBakey VA Medical Center Initiates Ph .. ia with Aeterna Zentaris' Ghrelin Agonist, AEZS-1
[ Thu, Mar 08th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the Barclays Capital 2012 Global Healthcare Conference
[ Thu, Mar 08th 2012 ] - Market Wire
Implant Sciences Sells More QS-H150 Explosives Trace Detection Devices to Chinese Airports
[ Thu, Mar 08th 2012 ] - Market Wire
OncoSec to Evaluate Potential Predictive or Progn .. t of Solid Tumor Cancers Using OMS ElectroImmunot
[ Thu, Mar 08th 2012 ] - Market Wire
Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
[ Thu, Mar 08th 2012 ] - Market Wire
Threshold Pharmaceuticals Reports Fourth Quarter .. d Year End 2011 Financial and Operational Results
[ Thu, Mar 08th 2012 ] - Market Wire
Sana Kliniken AG firma un acuerdo con Masimo para .. oluciones de supervisin de pacientes no invasivas
[ Thu, Mar 08th 2012 ] - Market Wire
Regeneron and Bayer Announce Approval of EYLEA (a .. Treatment of Wet Age-Related Macular Degeneratio
Wed, March 7, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
Law Firm Brower Piven Announces Investigation in .. on of Transcend Services, Inc. by Nuance Communic
[ Wed, Mar 07th 2012 ] - Market Wire
Resmed Inc. to Present at Upcoming Conferences
[ Wed, Mar 07th 2012 ] - Market Wire
International Drug &;; Explosives Detec .. ounces Strategic Alliance With an American Compan
[ Wed, Mar 07th 2012 ] - Market Wire
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
[ Wed, Mar 07th 2012 ] - Market Wire
Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
[ Wed, Mar 07th 2012 ] - Market Wire
Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial
[ Wed, Mar 07th 2012 ] - Market Wire
GenVec to Release Fourth Quarter and Year-End 201 .. s and Conduct a Conference Call on March 15, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN (lucinactant)
[ Wed, Mar 07th 2012 ] - Market Wire
iBio to Present at the 24th Annual ROTH Conference on March 14
[ Wed, Mar 07th 2012 ] - Market Wire
Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on March 14, 2
[ Wed, Mar 07th 2012 ] - Market Wire
Horizon Pharma Enters Into Exclusive Agreement Wi .. ization of LODOTRA(R) (Modified-Release Prednison
[ Wed, Mar 07th 2012 ] - Market Wire
CMS Assigns Payment to Novadaq's SPY Imaging Under OPPS
[ Wed, Mar 07th 2012 ] - Market Wire
Solta Medical Provides Update on Liposonix Launch
[ Wed, Mar 07th 2012 ] - Market Wire
The Ensign Group Acquires an Idaho Skilled Nursing Facility
[ Wed, Mar 07th 2012 ] - Market Wire
OncoSec's OMS ElectroImmunotherapy Technology Pla .. I Merkel Cell Carcinoma Clinical Trial Featured i
[ Wed, Mar 07th 2012 ] - Market Wire
Inovio Appoints Vaccine Industry Leader to its Scientific Advisory Board
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Discovery Labs Announces FDA Approval of SURFAXIN .. ) for Prevention of Respiratory Distress Syndrome
[ Tue, Mar 06th 2012 ] - Market Wire
TPI Updated Corporate Presentation at 32nd Cowen's Healthcare Conference
[ Tue, Mar 06th 2012 ] - Market Wire
PharmAthene to Host Year-End 2011 Earnings Conference Call and Webcast on Thursday, March 8, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
ProMetic Secures a $2.5 Million Follow on Agreement
[ Tue, Mar 06th 2012 ] - Market Wire
Lpath Raises $9.3 Million in Equity Financing
[ Tue, Mar 06th 2012 ] - Market Wire
CareFusion To Acquire Pharmacy Automation Technology Leader
[ Tue, Mar 06th 2012 ] - Market Wire
STATS ChipPAC's Scalable 3D eWLB Solutions Delive .. t Advantages Over Substrate-Based Package-on-Pack
[ Tue, Mar 06th 2012 ] - Market Wire
Comprehensive Care Corporation Expands Contract with Nation's Largest Public Health Plan
[ Tue, Mar 06th 2012 ] - Market Wire
More Regulation Looms for the Medical Equipment and Supplies Industry
[ Tue, Mar 06th 2012 ] - Market Wire
Shares of Antares Pharma and Boston Scientific on .. l Equipment and Supplies Industry Soaring in 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
[ Tue, Mar 06th 2012 ] - Market Wire
Titan Medical Inc. Announces Memorandum of Unders .. with Switzerland Based Clinique Generale-Beaulieu
[ Tue, Mar 06th 2012 ] - Market Wire
InspireMD Announces its 2011 Year End Financial Results
[ Tue, Mar 06th 2012 ] - Market Wire
Cytokinetics Announces That the European Medicine .. 57 Orphan Medicinal Product Designation for the T
[ Tue, Mar 06th 2012 ] - Market Wire
Rigel Announces Fourth Quarter and Year End 2011 Financial Results
[ Tue, Mar 06th 2012 ] - Market Wire
Shire to Initiate Two Phase 4 Clinical Trials to .. mine dimesylate) Capsules, (CII) to Concerta (met
[ Tue, Mar 06th 2012 ] - Market Wire
Implant Sciences Joins SOSSEC - Consortium of Lea .. rs in Security &;; Defense Technologies
[ Tue, Mar 06th 2012 ] - Market Wire
PAREXEL International to Present at Barclays Capital Healthcare Conference
[ Tue, Mar 06th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Oral Presenta .. 02 Clinical Study at the 2012 AACR Annual Meeting
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Cadence Pharmaceuticals to Host Conference Call a .. Quarter and Full Year 2011 Financial Results on M
[ Mon, Mar 05th 2012 ] - Market Wire
HealthSouth to Present at the Barclays Capital Global Healthcare Conference
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
VistaGen Therapeutics and Duke University Enter Into Strategic Research Collaboration
[ Mon, Mar 05th 2012 ] - Market Wire
BIOLASE Declares Stock Dividend for 2012 First Quarter
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
[ Mon, Mar 05th 2012 ] - Market Wire
Access Pharmaceuticals Announces Preliminary Four .. 9; MuGard Product Revenue Increases 400% Quar
[ Mon, Mar 05th 2012 ] - Market Wire
New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit
[ Mon, Mar 05th 2012 ] - Market Wire
Unigene's Proprietary Peptelligencea" Platform Se .. ealth Peptides for an Oral Phase 1 Clinical Study
[ Mon, Mar 05th 2012 ] - Market Wire
Sequenom Announces Participation at the 24th Annual Roth OC Growth Stock Conference
[ Mon, Mar 05th 2012 ] - Market Wire
Cytokinetics Announces Fundamental Research in th .. le Activation Published in the Journal Nature Med
[ Mon, Mar 05th 2012 ] - Market Wire
BioDelivery Sciences to Present at Cowen and ROTH Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference
[ Mon, Mar 05th 2012 ] - Market Wire
The Ensign Group Announces Acquisition of Doctors Express Franchise System
[ Mon, Mar 05th 2012 ] - Market Wire
OncoSec to Present at Cowen and ROTH Healthcare Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
BioLife Solutions Commences Build-Out of Second G .. P Production Suite and Corporate Office Expansion
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head amp;; .. ncers Induces Robust T-Cell Immune Response in Mi
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head & Neck and Ot .. ers Induces Robust T-Cell Immune Response in Mice
[ Mon, Mar 05th 2012 ] - Market Wire
diaDexus Launches PLAC Test for Lp-PLA(2) Activity in Europe
Fri, March 2, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
AMAG Pharmaceuticals, Inc. to Present at the 24th Annual ROTH Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Baxter Presents Long-Term Data on HyQ During AAAAI Annual Meeting
[ Fri, Mar 02nd 2012 ] - Market Wire
Illumina to Webcast Live Presentations at Upcoming Investment Conferences in March
[ Fri, Mar 02nd 2012 ] - Market Wire
Baxter Receives Marketing Authorization in Europe .. Union for VEPACEL Pre-Pandemic Influenza Vaccine
[ Fri, Mar 02nd 2012 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the Cowen and Co. Annual Health Care Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Barclays Capital Global Healthcare Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board
[ Fri, Mar 02nd 2012 ] - Market Wire
Mylan Continues to Pursue Damages and Injunction Against Sunovion's Brovana in Ongoing Litigation
[ Fri, Mar 02nd 2012 ] - Market Wire
Alere to Attend the Raymond James amp;; As .. stitutional Investors Conference on March 6, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
Warnex Extends Maturity Date of its Outstanding D .. entures and Provides Update on its Listing Status
[ Fri, Mar 02nd 2012 ] - Market Wire
Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
[ Fri, Mar 02nd 2012 ] - Market Wire
Syneron Closes Acquisition of Ultrashape Ltd.
[ Fri, Mar 02nd 2012 ] - Market Wire
Growing Medical Need for Cancer and Inflammation Treatment Benefits Cell Therapeutics and Zalicus
[ Fri, Mar 02nd 2012 ] - Market Wire
Amerigroup Expands Operations in Texas
[ Fri, Mar 02nd 2012 ] - Market Wire
Arena Pharmaceuticals Files European Marketing Au .. ion Application for Lorcaserin for Weight Control
[ Fri, Mar 02nd 2012 ] - Market Wire
Amgen Announces Initial Results of Tender Offer f .. omet, Inc. and Commencement of Subsequent Offerin
[ Fri, Mar 02nd 2012 ] - Market Wire
Orexigen Therapeutics Schedules March 8, 2012 Web .. Results for the Fourth Quarter and Year Ended Dec
[ Fri, Mar 02nd 2012 ] - Market Wire
ProMetic Announces Changes to Its Board of Directors
[ Fri, Mar 02nd 2012 ] - Market Wire
Media Advisory - Oncolytics Biotech Inc. to Prese .. en and Company 32nd Annual Health Care Conference

BD to Present at the Barclays Capital Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. rclays-capital-global-healthcare-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


BD to Present at the Barclays Capital Global Healthcare Conference -- FRANKLIN LAKES, N.J., March 9, 2012 /PRNewswire/ --

BD to Present at the Barclays Capital Global Healthcare Conference

[ ]

FRANKLIN LAKES, N.J., March 9, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: [ BDX ]), a leading global medical technology company, announced today that it will present at the Barclays Capital Global Healthcare Conference on Tuesday, March 13, 2012, at 2:00 p.m. (ET).

A live webcast of BD's presentation can be accessed from the BD corporate website at [ www.bd.com/investors ] and will be available for replay through Tuesday, March 20, 2012.

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit [ www.bd.com ].

Contact:
Monique N. Dolecki, Investor Relations – 201-847-5378
Colleen T. White, Corporate Communications – 201-847-5369

SOURCE BD (Becton, Dickinson and Company)

[ Back to top ]

RELATED LINKS
[ http://www.bd.com ]


Publication Contributing Sources